Home/Publication/Temasek Partners with HighLight Capital in Drug Discovery Play
Temasek Partners with HighLight Capital in Drug Discovery Play 

14 Jun 2023

US$ 19.00

Temasek Holdings (Pte) Ltd and its affiliate, True Light Capital Pte Ltd, have partnered with HighLight Capital to inves...

Price / article: US$19.00
OR existing subscriber
Related Publications

The Longreach Group (Longreach) announced the final closing of Longreach Capital Partners 4 (Longreach 4) at ......

Boost Capital, Global Catalyst Partners Japan, Gogin Capital, and Aichi Capital were party to the ¥2 billion (US$14...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.